ArticlePharmaceutical research2019

The Risk of QTc-Interval Prolongation in Breast Cancer Patients Treated with Tamoxifen in Combination with Serotonin Reuptake Inhibitors.

Koen G A M Hussaarts et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.